Check Product Availability
Updated January 15, 2019 02:06 PM
Hydroxyzine HCI
- 25 mg/mL | 1 mLSingle Dose Vial
- Shelf Pack — 25
Methylergonovine Maleate
- 0.2 mg/mL | 1 mLSingle Dose Vial
- Shelf Pack — 20
10% Calcium Chloride
- 1 Gram (100 mg/mL)
Represents 27 mg
(1.4 mEq) Ca++/mL | 10 mLSingle Dose Vial - Shelf Pack — 10
Fomepizole
- 1 g/mL | 1.5 mLSingle Dose Vial
- Shelf Pack — 1
Over 50 Years of Specialty Injectables
American Regent develops, manufactures and supplies high-quality sterile injectables for healthcare providers and their patients.
A Commitment to Affordable Care
We set a higher standard for responsiveness and reliability — applying innovative thinking to respond to customer needs.
News Center
American Regent Announces the Launch and Availability of Fomepizole Injection, AP Rated and Therapeutically Equivalent to Antizol®
Shirley, NY — American Regent today announced the launch and availability of Fomepizole Injection, AP rated and therapeutically equivalent to Antizol®.
St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship
The program offers fellowships in both Medical Affairs & Pharmaceutical Marketing and in Clinical Research & Development.
American Regent Announces the FDA Approval of Hydroxyprogesterone Caproate Injection, USP; the First Preservative Free, AP Rated Generic to Makena®
Shirley, NY — American Regent today announced the launch of Hydroxyprogesterone Caproate Injection, USP, the only preservative free generic alternative to Makena®.